Halozyme Therapeutics Elects New Board Member
I'm PortAI, I can summarize articles.
On December 4, 2025, Halozyme Therapeutics, Inc. announced the election of James Lang to its Board of Directors. Mr. Lang will serve until the annual meeting of stockholders in 2027.IndividualJames LangRoleDirectorType of ChangeAppointedEffective DateDec 4, 2025ReasonNot disclosedReplacement InfoN/ABackground DetailsN/ABoard/Committee Role ChangesNot disclosedOriginal SEC Filing: HALOZYME THERAPEUTICS, INC. [ HALO ] - 8-K - Dec. 08, 2025DisclaimerThis is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments